The United States Food and Drug Administration (FDA) on Friday (August 4) approved the use of the Zurzuvae (zuranolone) pill to treat postpartum depression (PPD) in adults. In a statement, the FDA said that the pill is to be taken once every day for 14 days during the evening with a fatty meal. The daily recommended dosage is 40 milligrams. The approval of Zurzuvae was granted to Sage Therapeutics, Inc, the statement added.
#fda #postpartum #depression
About Channel:
WION The World is One News examines global issues with in-depth analysis. We provide much more than the news of the day. Our aim is to empower people to explore their world. With our Global headquarters in New Delhi, we bring you news on the hour, by the hour. We deliver information that is not biased. We are journalists who are neutral to the core and non-partisan when it comes to world politics. People are tired of biased reportage and we stand for a globalized united world. So for us, the World is truly One.
Please keep discussions on this channel clean and respectful and refrain from using racist or sexist slurs and personal insults.
Subscribe to our channel at [ Ссылка ]
Check out our website: [ Ссылка ]
Connect with us on our social media handles:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Follow us on Google News for the latest updates
Zee News:- [ Ссылка ]
Zee Business:- [ Ссылка ]
DNA India:- [ Ссылка ]
WION: [ Ссылка ]
Zee News Apps: [ Ссылка ]
